Latest filing published 23 Oct 2018 for Arrowhead Pharmaceuticals, INC., €73k.
Filing timeline
BuySaleInsider track record
Peter Brian Leone: trading record in brief
This profile gathers the share dealings of Peter Brian Leone in Arrowhead Pharmaceuticals, Inc. Between 1 January 2017 and 19 October 2018, the trades on record add up to 6 filings.
Every open-market trade on record is a sale: 1 sale worth €1.5M. The rest of the record consists of 2 share grants and 3 option exercises. Since January 2018: no purchases and 1 sale on the market.
The record was last updated on 23 October 2018 with an option exercise (€73k) in Arrowhead Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Peter Brian Leone
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 shares@ US$2.793.2% of flowCommon StockSEC:0001209191-18-055999:0
- 34,375 shares@ US$6.158.2% of flowCommon StockSEC:0001209191-18-055999:1
- 66,762 shares@ US$7.7520.0% of flowCommon StockSEC:0001209191-18-055999:2
- 131,137 shares@ US$13.4968.5% of flowCommon StockSEC:0001209191-18-055999:3
- 40,000 shares0Common StockSEC:0001209191-18-001523:0
- 90,000 shares0Common StockSEC:0001209191-17-001617:0
6 of 6 declarations
